Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 03, 2018 |
referred to health |
May 11, 2017 |
referred to health |
Senate Bill S6256
2017-2018 Legislative Session
Sponsored By
(R, C, IP) Senate District
Archive: Last Bill Status - In Senate Committee Health Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
2017-S6256 (ACTIVE) - Details
2017-S6256 (ACTIVE) - Sponsor Memo
BILL NUMBER: S6256 TITLE OF BILL : An act to amend the public health law, in relation to limiting the initial prescription of a controlled substance for the alleviation of acute pain from a seven-day supply to a three-day supply PURPOSE : This bill would limit the number of schedule II, III or IV controlled substance pain pills initially prescribed to someone suffering from acute pain. This serves two important purposes: it encourages patients whose acute pain lasts longer than initially expected to follow-up with a doctor; and it lessens the number of pills left in medicine cabinets and available for diversion. SUMMARY OF PROVISIONS : Section one of the bill amends public health law § 3331(5)(b) to limit the initial prescriptions of any schedule II, III or IV controlled substance for acute pain to a 3 day supply. The term encompasses accidental and intentional pain lasting only a short or finite period of time. The subsection expressly excludes chronic pain, cancer pain, and hospice or other end-of-life care. Section two provides an immediate effective date.
2017-S6256 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 6256 2017-2018 Regular Sessions I N S E N A T E May 11, 2017 ___________ Introduced by Sen. HANNON -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to limiting the initial prescription of a controlled substance for the alleviation of acute pain from a seven-day supply to a three-day supply THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Paragraph (b) of subdivision 5 of section 3331 of the public health law, as added by section 1 of part C of chapter 71 of the laws of 2016, is amended to read as follows: (b) Notwithstanding the provisions of paragraph (a) of this subdivi- sion, a practitioner, within the scope of his or her professional opin- ion or discretion, may not prescribe more than a [seven-day] THREE-DAY supply of any schedule II, III, or IV opioid to an ultimate user upon the initial consultation or treatment of such user for acute pain. Upon any subsequent consultations for the same pain, the practitioner may issue, in accordance with paragraph (a) of this subdivision, any appro- priate renewal, refill, or new prescription for the opioid or any other drug. § 2. This act shall take effect immediately. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD11357-02-7
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.